Sign up USA
Proactive Investors - Run By Investors For Investors

GameStop shares plunge in early deals despite seeing increased in festive sales

Hardware sales increased 38.3%, driven the launch of the box One X and strong demand for Nintendo Switch
GameStop shares plunge in early deals despite seeing increased in festive sales
Gamestop said it was pleased with the sales performance..

Fortune 500 video gaming giant GameStop Corp (NYSE:GME) saw shares plunge 7% in early deals despite the group reporting a 10.6% increase in sales for the festive  period compared to the same time in 2016.

Sales of new video game software increased 7.3%, largely due to the success of Activision’s Call of Duty: WWII and the continued strength in Nintendo Switch titles.

Meanwhile,  hardware sales increased 38.3%, driven the launch of the box One X and  strong demand for Nintendo Switch.

But pre-owned sales declined 8.1%, as customers shifted their spending towards new video game and collectibles products.

Video game accessories sales grew a whopping 33.7%, mainly related to demand for Nintendo Switch accessories.

"We are pleased with our sales performance during the important holiday period, driven by strength in the Nintendo Switch and Xbox One X, and a solid increase in our collectibles business," said Dan DeMatteo, interim chief executive.

"Our results demonstrate our customers’ enthusiastic response to new products and our ability to execute on strategically targeted promotions.”

GameStop said it expects to deliver adjusted earnings per share near the middle of its previously announced full-year 2017 guidance of between $3.10 to $3.40.

The company also expects full-year fiscal 2017 comparable store sales to increase between 4% and 6% compared to the comparable 53 week period.

View full GME profile View Profile

GameStop Timeline

Newswire
November 02 2016

Related Articles

H&T Pawnbrokers store
November 15 2017
“We have delivered a strong trading performance during the second half in the key segments of Pawnbroking, Retail and Personal Loans”
Medical tests
July 11 2017
In an operational update, the medical services and software company said a multi-centre investigator led study comprising data from 607 patients at two academic university hospitals has now been completed

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You understand that the Company receives either monetary or securities compensation for our services. We stand to benefit from any volume this write-up may generate.

You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Copyright © Proactiveinvestors.com, 2018. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use